Graphite India Limited (GRAPHITE)
Earning Presentation for the quarter ended 30.06.2026
AI summary
- Consolidated Q1 FY27: Net Sales Rs 842 Cr +26.6% y-o-y; EBITDA Rs 241 Cr +24.9%; Net Profit Rs 171 Cr +28.6%
- Standalone Q1 FY27: Net Sales Rs 765 Cr +19.0%; EBITDA Rs 222 Cr +11.0%; Net Profit Rs 157 Cr +8.3%
- Capacity utilization rose to 97% in Q1 FY27 from 82% in Q1 FY26
- Electrode capacity expansion phase 1 to commission in FY27; SGAM project ongoing
- India steel production grew 7.5% y-o-y in 6M 2026; global steel production declined 0.3%
- Company closed German Specialities and Coating divisions due to geopolitical impact
- Net cash Rs 3,939 Cr consolidated; gross debt Rs 266 Cr
- Medium-term graphite electrode outlook cautiously optimistic amid EAF adoption
- Sustainability focus includes renewable energy generation
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GRAPHITE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GRAPHITE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Graphite India Limited
Important.
The summary above is generated automatically from Graphite India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.